Salipro Biotech
Stockholm, Sweden· Est.
Unlocking challenging drug targets for the development of next-generation therapeutics
Private Company
Total funding raised: $37.5M
About
Unlocking challenging drug targets for the development of next-generation therapeutics
Small Molecules
Funding History
3Total raised:$37.5M
Series B$25M
Series A$10M
Seed$2.5M